|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 8 (October 15), 1999:
pp. 2871-2879
Involvement of Interleukin-10 (IL-10) and Viral IL-6 in the Spontaneous
Growth of Kaposi's Sarcoma Herpesvirus-Associated Infected Primary
Effusion Lymphoma Cells
Karen D. Jones*,
Yoshiyasu Aoki*,
Yuan Chang,
Patrick S. Moore,
Robert Yarchoan, and
Giovanna Tosato
From the Division of Hematologic Products, Center for Biologics
Evaluation and Research, Food and Drug Administration, Bethesda, MD;
the Department of Pathology, School of Public Health, Columbia
University, New York, NY; and the HIV and AIDS Malignancy Branch,
National Cancer Institute, National Institutes of Health, Bethesda, MD.
Primary effusion lymphoma (PEL) is a distinct type of lymphoma
associated with Kaposi's sarcoma-associated herpesvirus (KSHV) infection. To determine the factors responsible for the unrestrained proliferation of PEL, we have studied the growth factor requirements of
the PEL-derived BCBL-1 and BC-1 cell lines. Both cell lines were found
to be autocrine growth factor dependent and to release human
interleukin-6 (IL-6), viral IL-6 (vIL-6), and human IL-10 in the
culture supernatant. To establish whether these cytokines contribute to
autocrine growth, neutralizing antibodies against human IL-6, vIL-6,
human IL-10, and soluble IL-10 receptor were used. These experiments
showed that human IL-10 and, to a lesser degree, vIL-6 serve as
autocrine growth factors for BCBL-1 and BC-1 cells. Thus, human IL-10
and vIL-6 are growth factors released and used by PEL cells for
autonomous proliferation and may be critical to the development and
progression of PEL.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
C. S. Dela Cruz, S. R. Viswanathan, A. S. El-Guindy, D. Shedd, and G. Miller
Complex N-Linked Glycans on Asn-89 of Kaposi Sarcoma Herpes Virus-encoded Interleukin-6 Mediate Optimal Function by Affecting Cytokine Protein Conformation
J. Biol. Chem.,
October 23, 2009;
284(43):
29269 - 29282.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. L. Calabro, P. Gasperini, I. M. Di Gangi, S. Indraccolo, M. Barbierato, A. Amadori, and L. Chieco-Bianchi
Antineoplastic activity of lentiviral vectors expressing interferon-{alpha} in a preclinical model of primary effusion lymphoma
Blood,
May 7, 2009;
113(19):
4525 - 4533.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bower, O. Veraitch, R. Szydlo, P. Charles, P. Kelleher, B. Gazzard, M. Nelson, and J. Stebbing
Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease
Blood,
May 7, 2009;
113(19):
4521 - 4524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Carbone, E. Cesarman, M. Spina, A. Gloghini, and T. F. Schulz
HIV-associated lymphomas and gamma-herpesviruses
Blood,
February 5, 2009;
113(6):
1213 - 1224.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Chen, G. Sandford, and J. Nicholas
Intracellular Signaling Mechanisms and Activities of Human Herpesvirus 8 Interleukin-6
J. Virol.,
January 15, 2009;
83(2):
722 - 733.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Gasperini, S. Sakakibara, and G. Tosato
Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesis
J. Leukoc. Biol.,
October 1, 2008;
84(4):
994 - 1000.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-J. Zhang, R. S. Bonaparte, D. Patel, D. A. Stein, and P. L. Iversen
Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus
Mol. Cancer Ther.,
March 1, 2008;
7(3):
712 - 720.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bower, T. Powles, S. Williams, T. N. Davis, M. Atkins, S. Montoto, C. Orkin, A. Webb, M. Fisher, M. Nelson, et al.
Brief Communication: Rituximab in HIV-Associated Multicentric Castleman Disease
Ann Intern Med,
December 18, 2007;
147(12):
836 - 839.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M-Q Du, C M Bacon, and P G Isaacson
Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders
J. Clin. Pathol.,
December 1, 2007;
60(12):
1350 - 1357.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Lubyova, M. J. Kellum, J. A. Frisancho, and P. M. Pitha
Stimulation of c-Myc Transcriptional Activity by vIRF-3 of Kaposi Sarcoma-associated Herpesvirus
J. Biol. Chem.,
November 2, 2007;
282(44):
31944 - 31953.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Davis, K. E. Singer, I. P. Reynolds, M. Haque, and R. Yarchoan
Hypoxia Enhances the Phosphorylation and Cytotoxicity of Ganciclovir and Zidovudine in Kaposi's Sarcoma-Associated Herpesvirus Infected Cells
Cancer Res.,
July 15, 2007;
67(14):
7003 - 7010.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-H. Sin, D. Roy, L. Wang, M. R. Staudt, F. D. Fakhari, D. D. Patel, D. Henry, W. J. Harrington Jr, B. A. Damania, and D. P. Dittmer
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling
Blood,
March 1, 2007;
109(5):
2165 - 2173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Chen and J. Nicholas
Structural Requirements for gp80 Independence of Human Herpesvirus 8 Interleukin-6 (vIL-6) and Evidence for gp80 Stabilization of gp130 Signaling Complexes Induced by vIL-6
J. Virol.,
October 1, 2006;
80(19):
9811 - 9821.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kovaleva, I. Bussmeyer, B. Rabe, J. Grotzinger, E. Sudarman, J. Eichler, U. Conrad, S. Rose-John, and J. Scheller
Abrogation of Viral Interleukin-6 (vIL-6)-Induced Signaling by Intracellular Retention and Neutralization of vIL-6 with an Anti-vIL-6 Single-Chain Antibody Selected by Phage Display.
J. Virol.,
September 1, 2006;
80(17):
8510 - 8520.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Arguello, S. Paz, E. Hernandez, C. Corriveau-Bourque, L. M. Fawaz, J. Hiscott, and R. Lin
Leukotriene A4 Hydrolase Expression in PEL Cells Is Regulated at the Transcriptional Level and Leads to Increased Leukotriene B4 Production.
J. Immunol.,
June 1, 2006;
176(11):
7051 - 7061.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. A. Keller, D. Hernandez-Hopkins, J. Vider, V. Ponomarev, E. Hyjek, E. J. Schattner, and E. Cesarman
NF-{kappa}B is essential for the progression of KSHV- and EBV-infected lymphomas in vivo
Blood,
April 15, 2006;
107(8):
3295 - 3302.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cannon, E. Cesarman, and C. Boshoff
KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2
Blood,
January 1, 2006;
107(1):
277 - 284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. A. Fielding, R. M. McLoughlin, C. S. Colmont, M. Kovaleva, D. A. Harris, S. Rose-John, N. Topley, and S. A. Jones
Viral IL-6 Blocks Neutrophil Infiltration during Acute Inflammation
J. Immunol.,
September 15, 2005;
175(6):
4024 - 4029.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Flano, B. Kayhan, D. L. Woodland, and M. A. Blackman
Infection of Dendritic Cells by a {gamma}2-Herpesvirus Induces Functional Modulation
J. Immunol.,
September 1, 2005;
175(5):
3225 - 3234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Uddin, A. R. Hussain, K. A. Al-Hussein, P. S. Manogaran, A. Wickrema, M. I. Gutierrez, and K. G. Bhatia
Inhibition of Phosphatidylinositol 3'-Kinase/AKT Signaling Promotes Apoptosis of Primary Effusion Lymphoma Cells
Clin. Cancer Res.,
April 15, 2005;
11(8):
3102 - 3108.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Johnston, I. N. Schwartzman, L. Flynt, and S. A. Shore
Role of interleukin-6 in murine airway responses to ozone
Am J Physiol Lung Cell Mol Physiol,
February 1, 2005;
288(2):
L390 - L397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Meads and P. G. Medveczky
Kaposi's Sarcoma-associated Herpesvirus-encoded Viral Interleukin-6 Is Secreted and Modified Differently Than Human Interleukin-6: EVIDENCE FOR A UNIQUE AUTOCRINE SIGNALING MECHANISM
J. Biol. Chem.,
December 10, 2004;
279(50):
51793 - 51803.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Lin, D. K. Crockett, S. D. Jenson, M. S. Lim, and K. S. J. Elenitoba-Johnson
Quantitative Proteomic and Transcriptional Analysis of the Response to the p38 Mitogen-activated Protein Kinase Inhibitor SB203580 in Transformed Follicular Lymphoma Cells
Mol. Cell. Proteomics,
August 1, 2004;
3(8):
820 - 833.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. S. Dela Cruz, Y. Lee, S. R. Viswanathan, A. S. El-Guindy, J. Gerlach, S. Nikiforow, D. Shedd, L. Gradoville, and G. Miller
N-linked Glycosylation Is Required for Optimal Function of Kaposi's Sarcoma Herpesvirus-encoded, but Not Cellular, Interleukin 6
J. Exp. Med.,
February 17, 2004;
199(4):
503 - 514.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. An, Y. Sun, and M. B. Rettig
Transcriptional coactivation of c-Jun by the KSHV-encoded LANA
Blood,
January 1, 2004;
103(1):
222 - 228.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Asadullah, W. Sterry, and H. D. Volk
Interleukin-10 Therapy--Review of a New Approach
Pharmacol. Rev.,
June 1, 2003;
55(2):
241 - 269.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Aoki, G. M. Feldman, and G. Tosato
Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma
Blood,
February 15, 2003;
101(4):
1535 - 1542.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cannon, N. J. Philpott, and E. Cesarman
The Kaposi's Sarcoma-Associated Herpesvirus G Protein-Coupled Receptor Has Broad Signaling Effects in Primary Effusion Lymphoma Cells
J. Virol.,
December 6, 2002;
77(1):
57 - 67.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Chatterjee, J. Osborne, G. Bestetti, Y. Chang, and P. S. Moore
Viral IL-6-Induced Cell Proliferation and Immune Evasion of Interferon Activity
Science,
November 15, 2002;
298(5597):
1432 - 1435.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-Q. Du, T. C. Diss, H. Liu, H. Ye, R. A. Hamoudi, J. Cabecadas, H. Y. Dong, N. L. Harris, J. K. C. Chan, J. W. Rees, et al.
KSHV- and EBV-associated germinotropic lymphoproliferative disorder
Blood,
October 16, 2002;
100(9):
3415 - 3418.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Li and J. Nicholas
Identification of Amino Acid Residues of gp130 Signal Transducer and gp80 {alpha} Receptor Subunit That Are Involved in Ligand Binding and Signaling by Human Herpesvirus 8-Encoded Interleukin-6
J. Virol.,
May 3, 2002;
76(11):
5627 - 5636.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Oksenhendler, E. Boulanger, L. Galicier, M.-Q. Du, N. Dupin, T. C. Diss, R. Hamoudi, M.-T. Daniel, F. Agbalika, C. Boshoff, et al.
High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease
Blood,
April 1, 2002;
99(7):
2331 - 2336.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Liu, Y. Okruzhnov, H. Li, and J. Nicholas
Human Herpesvirus 8 (HHV-8)-Encoded Cytokines Induce Expression of and Autocrine Signaling by Vascular Endothelial Growth Factor (VEGF) in HHV-8-Infected Primary-Effusion Lymphoma Cell Lines and Mediate VEGF-Independent Antiapoptotic Effects
J. Virol.,
November 15, 2001;
75(22):
10933 - 10940.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Aoki, M. Narazaki, T. Kishimoto, and G. Tosato
Receptor engagement by viral interleukin-6 encoded by Kaposi sarcoma-associated herpesvirus
Blood,
November 15, 2001;
98(10):
3042 - 3049.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Portis, J. C. Harding, and L. Ratner
The contribution of NF-{kappa}B activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors
Blood,
August 15, 2001;
98(4):
1200 - 1208.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Aoki, G. Tosato, T. W. Fonville, and S. Pittaluga
Serum viral interleukin-6 in AIDS-related multicentric Castleman disease
Blood,
April 15, 2001;
97(8):
2526 - 2527.
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Li, H. Wang, and J. Nicholas
Detection of Direct Binding of Human Herpesvirus 8-Encoded Interleukin-6 (vIL-6) to both gp130 and IL-6 Receptor (IL-6R) and Identification of Amino Acid Residues of vIL-6 Important for IL-6R-Dependent and -Independent Signaling
J. Virol.,
April 1, 2001;
75(7):
3325 - 3334.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M.-Q. Du, H. Liu, T. C. Diss, H. Ye, R. A. Hamoudi, N. Dupin, V. Meignin, E. Oksenhendler, C. Boshoff, and P. G. Isaacson
Kaposi sarcoma-associated herpesvirus infects monotypic (IgM{lambda}) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders
Blood,
April 1, 2001;
97(7):
2130 - 2136.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Aoki, R. Yarchoan, K. Wyvill, S.-i. Okamoto, R. F. Little, and G. Tosato
Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders
Blood,
April 1, 2001;
97(7):
2173 - 2176.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Nicholas
Evolutionary aspects of oncogenic herpesviruses
Mol. Pathol.,
October 1, 2000;
53(5):
222 - 237.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
E. Oksenhendler, G. Carcelain, Y. Aoki, E. Boulanger, A. Maillard, J.-P. Clauvel, and F. Agbalika
High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients
Blood,
September 15, 2000;
96(6):
2069 - 2073.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Aoki, R. Yarchoan, J. Braun, A. Iwamoto, and G. Tosato
Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions
Blood,
August 15, 2000;
96(4):
1599 - 1601.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
